These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14347869)

  • 1. THE EFFECT OF COPPER IONS ON CLOT LYSIS TIME IN THE FIBRINOLYTIC ASSAY OF STREPTOKINASE.
    BOGERT AB
    Thromb Diath Haemorrh; 1965 Jun; 13():477-83. PubMed ID: 14347869
    [No Abstract]   [Full Text] [Related]  

  • 2. ACTIVATION OF THE FIBRINOLYTIC SYSTEM IN HUMAN BLOOD BY STREPTOKINASE AND CHANGES IN THIS SYSTEM AND IN THE EUGLOBULIN CLOT LYSIS TIME IN RELATION TO AGE AND SEX.
    KONTTINEN YP
    Scand J Clin Lab Invest; 1965; 17():SUPPL 82:1-111. PubMed ID: 14320094
    [No Abstract]   [Full Text] [Related]  

  • 3. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. A new method for determination of preformed clot lysis.
    BLIX S
    Acta Med Scand Suppl; 1962; 386():1-24. PubMed ID: 13971658
    [No Abstract]   [Full Text] [Related]  

  • 4. Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Lab Clin Med; 1961 Apr; 57():620-9. PubMed ID: 13700257
    [No Abstract]   [Full Text] [Related]  

  • 5. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 6. [FIBRINOLYTIC PROPERTIES OF THE CONTACT FACTOR].
    AZNAR J
    Rev Esp Fisiol; 1964 Jun; 20():43-51. PubMed ID: 14185256
    [No Abstract]   [Full Text] [Related]  

  • 7. [A contribution to fibrinolytic therapy with streptokinase and streptolysin].
    FISCHBACHER W
    Thromb Diath Haemorrh; 1961 Dec; 6():547-72. PubMed ID: 13893097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the effect of urokinase on the fibrinolytic activity of the blood].
    ANDREENKO GV; STRUKOVA SM
    Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411
    [No Abstract]   [Full Text] [Related]  

  • 9. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 10. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 11. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I; AAS K; GODAL HC
    Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
    [No Abstract]   [Full Text] [Related]  

  • 13. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methodological research on the control of fibrinolytic therapy with streptokinase].
    CROLLE G; MARX R
    Rass Fisiopatol Clin Ter; 1962; 34():17-45. PubMed ID: 13882309
    [No Abstract]   [Full Text] [Related]  

  • 15. EVALUATION OF THE FIBRINOLYTIC STATE AFTER ADMINISTRATION OF UROKINASE.
    BAUMGARTEN W; PRIESTER LI; HERCZEG SA; WATSON LS
    Proc Soc Exp Biol Med; 1964 Apr; 115():1120-4. PubMed ID: 14166574
    [No Abstract]   [Full Text] [Related]  

  • 16. POST MORTEM ACTIVATION OF HUMAN BLOOD FIBRINOLYTIC ENZYME IN SUDDEN AND NATURAL DEATHS.
    HABA K; KUMANO O; MOHRI M; TAKEMARU H; KAWANISHI K; TOBE S; KAMADA T; UENO S
    Acta Med Okayama (1952); 1963; 17():279-88. PubMed ID: 14168972
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 18. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
    LEWIS JH; KERBER CW; WILSON JH
    Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY].
    KAPPERT A
    Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE STATUS OF THE BLOOD FIBRINOLYTIC ACTIVITY IN HEMOPHILIA PATIENTS].
    EFENDIEV FA; AKHUNDOVA AM; ABDULLAEV MM; EFENDIEV ZI
    Klin Med (Mosk); 1963 Jan; 41():122-5. PubMed ID: 14121310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.